Volume 376, Issue 9750, Pages (October 2010)

Slides:



Advertisements
Similar presentations
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants The Lancet Volume 387, Issue 10027,
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
BMI and risk of dementia in two million people over two decades: a retrospective cohort study  Dr Nawab Qizilbash, MRCP, John Gregson, PhD, Michelle E.
Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study  Oliver J Brady, DPhil, Hannah C Slater,
UK investments in global infectious disease research 1997–2010: a case study  Michael G Head, PGDip, Joseph R Fitchett, MSc, Mary K Cooke, MSc, Fatima.
Prof Rifat Atun, FRCP, Sachin Silva, MSc, Prof Felicia M Knaul, PhD 
The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics  Prof Andrew J Tatem, PhD, Peng Jia, PhD,
Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis  Dr Michael G Head, PhD, Sian Goss, MSc, Yann Gelister, MSc, Victor.
Thank God for Richard Dawkins?
Volume 383, Issue 9930, Pages (May 2014)
Brian J Coburn, David J Gerberry, Sally Blower 
Helen Cox, Mark P Nicol  The Lancet Infectious Diseases 
Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis  Freya M Shearer, BSc, Catherine L Moyes, PhD, David M.
Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling study  Isaac I.
Volume 12, Issue 1, Pages (January 2013)
Underestimate of annual malaria imports to Canada – Author reply
New global estimates of malaria deaths
Volume 4, Issue 12, Pages (December 2017)
Volume 366, Issue 9499, Pages (November 2005)
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study  Dr R McGready,
Aspirin in the prevention of cancer – Author's reply
Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis  Dr Michael G Head, PhD, Sian Goss, MSc, Yann Gelister, MSc, Victor.
Prof Seena Fazel, MD, Taanvi Ramesh, MSc, Prof Keith Hawton, FMedSci 
Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data  Dr Anna Maria van Eijk, MD,
Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants 
Volume 381, Issue 9870, Pages (March 2013)
Brian J Coburn, Sally Blower  The Lancet Infectious Diseases 
Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis  Freya M Shearer, BSc, Catherine L Moyes, PhD, David M.
Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment  Jonathan Pearson-Stuttard, BMBCh,
Access to emergency hospital care provided by the public sector in sub-Saharan Africa in 2015: a geocoded inventory and spatial analysis  Paul O Ouma,
Volume 381, Issue 9870, Pages (March 2013)
Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study  Nabihah Sachedina, MBBS, Prof.
An update on Zika virus infection
HIV myths should not be resuscitated
Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis  Ulla Beijer, PhD, Achim Wolf, MSc, Dr.
Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study  Jue Liu, PhD, Shikun Zhang, MD,
Effect of development assistance on domestic health expenditures
UK investments in global infectious disease research 1997–2010: a case study  Michael G Head, PGDip, Joseph R Fitchett, MSc, Mary K Cooke, MSc, Fatima.
A voracious creature The Lancet Volume 358, (December 2001)
Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study  Oliver J Brady, DPhil, Hannah C Slater,
Prevalence of malaria infection in pregnant women compared with children for tracking malaria transmission in sub-Saharan Africa: a systematic review.
Cold water immersion: sudden death and prolonged survival
What would happen if we stopped vaccination?
Volume 4, Issue 10, Pages (October 2017)
Volume 372, Issue 9649, Pages (November 2008)
Volume 392, Issue 10164, Pages (December 2018)
Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.
The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics  Prof Andrew J Tatem, PhD, Peng Jia, PhD,
Confessions of a journal junkie
Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa,
Infant-feeding patterns and HIV-1 transmission
Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment  Jonathan Pearson-Stuttard, BMBCh,
Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study  Dr Patrick.
Individual-level factors associated with the risk of acquiring human Plasmodium knowlesi malaria in Malaysia: a case-control study  Dr Matthew J Grigg,
Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis  Freya M Shearer, BSc, Joshua Longbottom, MSc, Annie J Browne,
Telling it like it isn't: truth and lies in a post-9/11 world
Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study 
Anna J Dare, Calvin Ke, Wilson Suraweera, Peter Rodriguez, Prabhat Jha 
Thank God for Richard Dawkins?
Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD  The Lancet 
Thank you to our diverse (but not diverse enough) reviewers
Measuring malaria endemicity from intense to interrupted transmission
Volume 392, Issue 10160, Pages (November 2018)
Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review  Alexander K Rowe,
Ebola control: rapid diagnostic testing
Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15  Prof Peter Lloyd-Sherlock,
Environmental risk factors and exposure to the zoonotic malaria parasite Plasmodium knowlesi across northern Sabah, Malaysia: a population-based cross-sectional.
Volume 383, Issue 9930, Pages (May 2014)
Autism, maths, and sex: the special triangle
Volume 394, Issue 10195, Pages (July 2019)
Presentation transcript:

Volume 376, Issue 9750, Pages 1409-1416 (October 2010) Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments  Prof Robert W Snow, FMedSci, Emelda A Okiro, PhD, Peter W Gething, PhD, Prof Rifat Atun, FFPHM, Simon I Hay, DPhil  The Lancet  Volume 376, Issue 9750, Pages 1409-1416 (October 2010) DOI: 10.1016/S0140-6736(10)61340-2 Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 1 Per-person at-risk donor assistance (US$) by 2007 and 2009 across 93 malaria-endemic countries where stable transmission exists The Lancet 2010 376, 1409-1416DOI: (10.1016/S0140-6736(10)61340-2) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 2 Populations at risk of stable Plasmodium vivax or Plasmodium falciparum (PfPv PAR) versus cumulative funding commitments (US$) to 80 countries that had received funding by the end of 2009 Does not include two outliers: India with a huge population at risk, 758 million people, but receives only about $0·03 per person at risk per year, and Nigeria because it has more than 167 million people at risk of stable P falciparum infection, distorting the plot of funding and populations at-risk worldwide. In Nigeria funding increased since 2007 from $0·73–1·71 per person at risk in 2009. The Lancet 2010 376, 1409-1416DOI: (10.1016/S0140-6736(10)61340-2) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 3 Prioritisation for international donor support based on current per-person per year external malaria donor support and expected needs for 2010 The Lancet 2010 376, 1409-1416DOI: (10.1016/S0140-6736(10)61340-2) Copyright © 2010 Elsevier Ltd Terms and Conditions